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A B S T R A C T
Introduction: Prevention of psychosis has become a major objective of modern clinical psychiatry. An
increasing number of new services have been established in Europe and in the world. The OASIS team has
become an established model where clinical practice and research are fully integrated in the ﬁeld of
preventative interventions in psychosis.
Method: Comprehensive analysis of different clinical and service measures describing the 2001–
2011 implementation of the OASIS team.
Results: Over the last decade, the OASIS team has received a total of 1102 referrals, mostly young males
from ethnic minorities. After the assessment, 35% were diagnosed with an At Risk Mental State (ARMS)
while 32% were already psychotic. Within the ARMS, 70% met the inclusion criteria for the attenuated
psychotic symptoms subgroup, 1% met the inclusion criteria for the genetic deterioration syndrome, 9%
met inclusion criteria for a brief and self-limited intermittent psychotic episode and the others met
inclusion criteria for more than one subgroup. Most of them had at least one comorbid diagnosis, mainly
relating to anxiety and depressive domains. The majority of the OASIS clients received cognitive
behavioural therapy alone or in combination with antidepressants/antipsychotics. Over the 2-year
follow-up time, 44 subjects (15.2%) developed a frank psychotic episode.
Conclusions: The OASIS service represents one of the largest and most established prodromal services in
the world. The burden of research evidence and the translational impact produced on the clinical
practice support the OASIS as a model for the development of similar services.
 2012 Published by Elsevier Masson SAS.
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Although the notion that the onset of psychosis is usually
preceded by a ‘‘prodromal’’ phase was ﬁrst recognized by Mayer-
Gross in 1932 [50], formal PubMed research appeared only about
20 years ago in a pioneering work by Huber et al. (1989) [44].
Inﬂuenced by Mayer-Gross’ observations, Huber ﬁrst described
basic symptoms in the 1960s and initiated the ﬁrst prospective
early detection study in the 1980s [44]. Since then, there has been
an exponential clinical and research interest into the high risk state
for psychosis (for a comprehensive and up-to-date conceptual
review see Fusar-Poli et al. [17]). It is now clear that the high risk
state (variably termed as At Risk Mental State, ARMS or Ultra High
Risk, UHR or Clinical High Risk, CHR) is associated with an* Corresponding author. Tel.: +44 0 20 7848 0900; fax: +44 0 20 7848 0976.
E-mail address: p.fusar@libero.it (P. Fusar-Poli).
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Open access under CC BY-NC-ND license.increased probability of developing a psychotic disorder – mainly
schizophrenia spectrum disorders [21] – over time, from 18% at six
months up to 36% after three years [36]. Broadly speaking the high
risk state is characterized by the presence of subtresholded
psychotic symptoms, cognitive and neurobiological deﬁcits
[28,37,31,16] and signiﬁcant limitations in psychosocial function-
ing [1]. A growing interest in this area has lead to the discussed
proposal of including a new high risk diagnostic category in the
forthcoming DSM-5 [15]. In such a scenario, the Outreach and
Support in South London (OASIS) team has played a pivotal role as
one of the ﬁrst and largest services in the world devoted to the
diagnosis and clinical management of potential prodromal
psychosis. In about one decade, the OASIS team has become an
established model where clinical practice and research are fully
integrated in the ﬁeld of preventative interventions in psychosis. In
this article we will present the progresses that have been made
since the development of the OASIS service, while recognizing at
the same time the future challenges.
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2.1. Sample
All subjects with ‘‘at risk’’ signs or symptoms for psychosis
referred to the OASIS service for assessment and diagnosis over the
past decade (2001–2011) were included in the present analysis.
2.2. Outcome variables
The present study has evaluated the impact of the OASIS service
on three outcome measures:
 diagnosis of high risk subjects;
 clinical management of subjects with an enhanced risk for
psychosis;
 implementation of a clinical-academic model for ongoing
research in the mental health services.
The ﬁrst outcome was analyzed with respect to the develop-
ment of local early intervention services, description of the
catchment area (number of referrals, psychometric assessment
of presenting psychopathology, inclusion and exclusion criteria,
differential diagnosis, deﬁnition of different high risk subgroups,
pathways to care, assessment of social functioning and comorbid
diagnoses). The second outcome was analyzed with respect to the
logistic demands for the implementation of prodromal services,
clinical outcomes relevant to the treatment of high risk patients
(case management, focused interventions, transition outcomes,
integration with ﬁrst-episode services, treatment of patients in
prison) and economic considerations. The third outcome was
analyzed with respect to the development of clinical academic
groups, neuroimaging investigations of subjects at risk for
psychosis and by discussing other research approaches.
2.3. Statistical analysis
Descriptive statistics included mean and standard deviation for
continuous variables and absolute and relative frequencies for
categorical variables. Histograms and pies were used to better
describe each speciﬁc outcomes. Survival curves were calculated
by Kaplan-Meier estimates along with the Log-rank test. Data were
analyzed with IBM SPSS20.
3. Results
3.1. Diagnosis
3.1.1. Development of early interventions in South London and the
Maudsley
The development of the early intervention services in South
London and the Maudsley (SLaM) began in 1997, when short-
comings in existing services for young people with ﬁrst-episode
psychosis were ﬁrst identiﬁed by an internally commissioned
report in Lambeth called ‘Bridging the Gap’ [57]. The ﬁrst service,
the Lambeth Early Onset (LEO) Community Team began operation
in January 2000 as an extended hours service from a small clinic
near central Brixton [57]. As the LEO Community Team was being
established a new acute 18-bed adult inpatient unit was
commissioned at Lambeth Hospital in 2001, where it is still
located. Furthermore, a Crisis and Assessment Team (LEO CAT) was
developed in 2002 to target GPs, improve their detection and
referral rates, and provide quick access for community based
assessments and engagement into the ﬁrst episode services [57].
The OASIS team was developed at the same time (2001) in theLambeth borough to identify subjects at high clinical risk for
psychosis [7].
3.1.2. Catchment area
The OASIS team is currently covering a wide urban area in South
London catering for clients in four different boroughs (Lewisham,
Croydon, Lambeth, Southwark). The overall catchment area is of
about 1.18 million of citizens (Lewisham 264,500, Croydon
342,800, Lambeth 283,300, Southwark 285,600)(UK government
national statistic; http://data.london.gov.uk/datastoreﬁles/visua-
lisations/atlas/fol10-pop&mig-2010/atlas.html). The OASIS service
is fully integrated with the new ﬁrst-episode services, which have
been developed in each of the above boroughs: Southwark Team
for Early Psychosis (STEP); Lewisham Early Intervention Service
(LEIS); Lambeth Early Onset Psychosis (LEO) and Croydon Outreach
Assessment Support Team (COAST) (Fig. 1). The clinical manage-
ment of these services has undergone a profound change with the
development of the new NHS-Institute of Psychiatry Clinical
Academic Groups (CAGs) (see the paragraph below here).
South London is well recognized as having one of the highest
rates of psychosis in the UK [46] and one of the highest in the
world. There are different reasons underlying the high incidence of
psychosis in this area. For example, Lambeth has high proportion of
Black and other ethnic minorities residents and the highest
proportion of African–Caribbean residents in London. Consistent
evidence indicates in the UK African-Caribbeans and Black Africans
are at especially high risk for both schizophrenia and mania [14].
South London has a large migrant population [54] and migration
has been associated with higher risk for psychosis [8]. The
unemployment rate in this area is high as well as the proportions of
households and homelessness. Social fragmentation, urbanicity
and deprivation have all been associated with an elevated risk of
developing psychosis in the general population [2]. Fig. 2
summarizes the 2010 deprivation index of the different boroughs
in London, illustrating the picture given above here.
The additional concern is that the proportion of drug use in
these areas is quite high. In particular there has been a worrying
trend towards the utilization of street cannabis with higher
concentration of d-9-tetrahydrocannabinoid, which is the active
ingredient increasing the risk of psychosis [12]. Overall, in the 15–
35 age group, the rate of new cases of psychosis is approximately
65/100,000 [46]. The local prevalence of the ARMS is unknown, but
if it is correlated with the incidence of psychosis, it is likely to be
comparably high.
3.1.3. Referrals and prescreening
Referrals are usually accepted by telephone, mail and fax and
can be done by service user’s friend, or relatives as well as health
professionals. The diagnostic process at the OASIS team includes
three steps:
 prescreening;
 screening assessment;
 baseline assessment.
First, the individual referred is contacted by telephone to check
the suitability of the referral (pre-screening). The OASIS team is
continuously developing educational programmes in liaison with
local health and non-health agencies who may encounter people
potentially meeting the inclusion criteria. Mental health charities
and voluntary organizations, local pastoral and educational
services are also informed about the OASIS team. The concept of
the potential prodrome or ARMS is unfamiliar to most health care
professional such as primary care physicians (GP’s), primary care
counsellors, college and university counsellors, community mental
Fig. 1. Early intervention services in South London and Madusley (SLaM, Southwark, Lambeth, Lewisham, Croydon). In yellow prodromal teams, in orange ﬁrst episode teams.
OASIS: Outreach and Support in South London prodromal service; STEP: Southwark Team for Early Psychosis; LEIS: Lewisham Early Intervention Service; LEO: Lambeth Early
Onset Psychosis; COAST: Croydon Outreach Assessment Support Team. The inpatient unit for ﬁrst-episode psychotic patients is not represented.
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educational programme is continuously ongoing and includes
informal meetings, presentations and distribution of information
materials. Information is also posted on a website (http://Fig. 2. 2010 Deprivation indices for London Boroughs. South London, where the OASIS
Source: Indices of Deprivation, Department of Communities and Local Government, Crow
4D8E-8BAF-5CA643A5327B/0/DP_PL_DeprivationIndex2010_v2.pdf.www.slam.nhs.uk/our-services/oasis.aspx), and distributed in
leaﬂets and newsletters. This training and educational effort has
been effective, as the OASIS team to date has received a total of
1102 referrals (2001–2011, Fig. 3). Furthermore, the referral rate team is based, is characterized by a high level of social deprivation.
n Copyright 2010 http://www.cityoﬂondon.gov.uk/NR/rdonlyres/F3E4FC12-AF75-
Fig. 3. Number of referrals (n = 1102) to the OASIS team over the past 10 years
(2001–2011).
Table 1
Demographic characteristics of 2001–2011 OASIS referrals (column on the left).
SLaM, South London and the Maudsley NHS Foundation Trust. The second column
on the right shows the demographic characteristics of the subgroup of subjects who
met At Risk Mental State (ARMS) after the OASIS assessment.
All referrals (n = 1102) ARMS (n = 290)
Age in years (SD) 23.52 (5.05) 22.9 (4.61)
Gender (% male) 60.4 56.1
Place of birth (%)
United Kingdom 71.3 77.6
Africa 9.7 6.3
Europe (outside UK) 6.4 7.3
Caribbean 3.3 4.5
Middle East 1 0.7
South America 0.9 0.7
Other 7.4 2.9
Ethnicity (%)
White British 33.1 39.9
Caribbean and African 19.2 14.6
Black British 17.2 20.5
Other White 9.5 12.2
Mixed 5.7 5.9
Asian Oriental 1.2 1
Middle East 1.6 1.4
Asian Indian 2.7 2.8
Other 9.8 1.7
Living area (%)
Lambeth 61.2 63.1
Southwark 27.9 31
Lewisham 6 2.4
Croydon 2.6 1.4
Outisde SLaM 2.3 2.1
Employment (%)
Student 27.9 26.9
Unemployed 49.2 45.6
Employed 22.9 27.5
Marital status (%)
Single 81.3 81.5
Married/living with partner 10.3 13.6
Separated/divorced 3.8 4.9
Other 4.6 0
Drug use (%)
Yes 37.2 38.1
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year (4.52 referrals/week).
Most of the OASIS referrals (28%) came from GPs, followed by
community mental health services or child and adolescent services
(18%) and ﬁrst-episode services (16%)(Fig. 4). Only 11% were self-
referrals while other referrers included emergency clinics, relatives
or counsellors.
Overall, those referred were predominantly young (mean age
23.5, SD 5.5) males (60.4%). Most of them (71.3%) were born in UK
and where from ethnic minorities (white British 33.1%). A
substantial proportion of clients was born in African or Caribbean
countries (19.2%). Given that OASIS was ﬁrst set up in Lambeth, the
majority of referrals came from this borough (61.2%). About half of
the referred clients was unemployed (49.2%) and one third of them
(37.2%) admitted using illicit drugs during the pre-screening
assessment. The sociodemographic details of the whole cohort are
presented in Table 1.Fig. 4. Sources of referrals to the OASIS team (2001–2011, n = 1102). CMHT:
Community Mental Health Teams; CAMHS: Community Adolescent Mental Health
Services; IAPT: Improving Access to Psychological Therapies; A&E: Accident and
Emergency services.
No 62.8 61.93.1.4. Screening and baseline assessments
The initial screening assessment is usually offered at the
client’s general practice, alternatively at the team base or their
home, usually comprising one session. A psychiatrist and/or a
clinical psychologist typically assess clients. The age range is of
14–35, consistent with that employed by the Personal
Assessment and Crisis Evaluation (PACE) clinic in Melbourne
[80]. The assessment is performed through a clinical interview
supported by the Comprehensive Assessment of the At Risk
Mental State (CAARMS) [77], a semi structured interview
designed to assess putative prodromal psychotic symptoms in
help-seeking individuals. The scale has a total of 27 items,
which can be clustered in seven subscales. The ﬁrst four items
on the CAARMS, which cover attenuated delusions, hallucina-
tions, thought disorder and disorganised speech, are usually
summed to give a total score for attenuated ‘positive’ psychotic
symptoms and are used to assess the inclusion criteria for an
ARMS during the screening assessment. If the client meets
ARMS criteria and is taken on by the OASIS team, the remaining
scales of the CAARMS are then completed during a subsequent
baseline assessment. Since 2008 the OASIS team has been
employing a revised and extended version of the CAARMS
P. Fusar-Poli et al. / European Psychiatry 28 (2013) 315–326 319(CAARMS + COGDIS, see below), which includes additional
items from the SPIA scale [61]. Level of functioning is evaluated
with the Global Assessment of Functioning (GAF) scale [40] and
by the Social and Occupational Functioning Assessment Scale
(SOFAS) [38]. The baseline assessment is quite demanding in
terms of time and usually takes up to two sessions to be
completed (see below).
3.1.5. Inclusion high risk criteria
OASIS inclusion criteria apply to helpseeking subjects only
and require the presence of one or more of the following
subgroups:
 attenuated psychotic symptoms (APS). The APS criterion
identiﬁes young people at risk of psychosis due to a subthreshold
psychotic syndrome. That is, they have symptoms which do not
reach threshold levels for psychosis due to subthreshold
intensity (the symptoms are not severe enough) or they have
psychotics symptoms but at a subthreshold frequency (the
symptoms do not occur often enough);
 brief limited intermittent psychotic episode (BLIP), deﬁned as the
presence of a psychotic episode of less than seven days which
remits spontaneously with no medication or hospitalization;
 a trait vulnerability plus a marked decline in psychosocial
functioning (Genetic Risk and Deterioration Syndrome [GRD]).
The GRD criterion identiﬁes young people at risk of psychosis due
to the combination of a trait risk factor and a signiﬁcant
deterioration in mental state and/or functioning: family history
of psychosis in ﬁrst degree relative or schizotypal personality
disorder in identiﬁed patient;
 the fourth group is the cognitive perceptive basic symptoms (BS)
group (since 2008). The BS criterion identiﬁes at risk persons on
the basis of subtle cognitive and perceptive alterations. Basic
symptoms are subjective disturbances of thought processing,
language and attention that are distinct from classical psychotic
symptoms, in that they are independent of abnormal thought
content [60]. Basic symptoms were originally assessed using the
Bonn Scale for the Assessment of Basic Symptoms (BSABS) [47]
and, more recently, the Schizophrenia Proneness Instrument,
Adult Version (SPI-A), which allows a frequency-based severity
rating of basic symptoms. These instruments inventory focus on
self-perceived cognitive and perceptual changes, ultimately
clustered in two partially overlapping subsets relating to the
COPER (ten cognitive-perceptive basic symptoms) and the
COGDIS criteria (the nine cognitive basic symptoms that are
the most predictive of later psychosis) [62]. The revised version
of the CAARMS employed at the OASIS includes these 9-COGDIS
items from the SPIA scale: Inability to divide attention (A.8.4)
from the Cognitive-Attentional Impediments (B, ATTENT)
subscale; thought interference (C.1.1), blockages (C.1.4), distur-
bance of receptive (C.1.6) and expressive (C.1.7.) speech from the
Cognitive Disturbances (C, COGNIT) subscale; thought pressure
(C.1.3), unstable ideas of references (C.1.17), from the Distur-
bances in Experiencing the Self and Surroundings (D, SELF)
subscale; disturbances of abstract thinking (C.1.16), captivation
of attention by details of the visual ﬁelds (C.2.9) from the
Optional (O) subscale. As indicated on the SPIA scale, severity
score should be at least 3 for at least two basic symptoms in the
past three months.
For all the four groups above here the additional requirement is
that the symptoms should be present in the past year with a 30%
drop in GAF score from premorbid level, sustained for a month and
within the past 12 months or SOFAS score less than 50 for the past
12 months or more.3.1.6. Exclusion criteria
OASIS exclusion criteria are:
 history of frank psychotic episodes;
 previous exposure to antipsychotic agents;
 current substance dependence;
 deﬁcits in general intelligence (IQ < 70);
 neurological disorders or any medical condition;
 clients not help-seeking or withdrawing their willingness to be
followed by the service;
 age range outside than 14–35.
Inclusion and exclusion criteria are discussed in the clinical
meeting with the team and a decision is made trough consensus.
3.1.7. Differential diagnosis
Of the 1102 referrals received from 2001 to 2011, 271 were not
assessed because one of the following reasons: having been screened
out due to living outside of the boroughs served by SLaM NHS
Foundation Trust, being outside of the age range of the service, or the
patient’s refusal to undergo the assessment or recurrently failing to
meet with the team. Among the 831 subjects who were assessed,
290 of them (35%) received a diagnosis of an ARMS (ARMS intake in
2011 was of 7 ARMS/month)(Fig. 5). Of interest, about 32% of the
subjects who were referred because of putative prodromal
symptoms were already frankly psychotic at the time of their
referral to the team (Fig. 5). More importantly, almost all the subjects
referred to the OASIS team met at least one diagnostic criteria for
some psychiatric disorder. All subjects who did not meet ARMS
criteria had at least an alternative psychiatric diagnosis (only in less
than 4% there was no evidence of psychiatric disorders).
3.1.8. ARMS subgroups
Within the ARMS, the vast majority met the APS criterion (70%)
followed by APS + GRD (11%) and BLIP (9%). The proportion of each
soubgroup is depicted in Fig. 6, while the sociodemographic
characteristics of the ARMS are detailed in Table 1.
3.1.9. Pathways to care
Of the 290 ARMS clients, 28% was referred by the GPs, 11% was self-
referred, 18% was referred by a community adult/adolescent mental
health service, 16% was referred from a ﬁrst-episode team and the
remaining ones were was referred from counsellors, from the OASIS in
prison team, or from other charity or voluntary agencies.
3.1.10. Social functioning
The experience of at risk symptoms per se is associated with a
marked impairment in psychosocial  functioning [71], which
appears as a core feature of the prodromal state [63]. Social
impairment plays a signiﬁcant role in the etiopathology of the
disease onset and is an independent predictor of longitudinal
outcome [29] being resistant to treatment, pharmacological and
psychosocial [9]. It is also reﬂected by a considerably decreased
subjective quality of life [58,5]. Clients of the OASIS team are
more likely to live in communal establishments or at home with
their parents than the local population [29]. The OASIS patients
show also higher rates of unemployment than the general
population [29].
3.1.11. Presenting symptoms and diagnostic comorbidities
In addition to APS symptoms, help-seeking people who meet
criteria for ARMS usually present with other clinical concerns.
Many have comorbid diagnoses, in particular anxiety, depression,
and substance use disorders that are clinically debilitating [80,74].
High levels of negative symptoms, signiﬁcant impairments in
Fig. 5. Differential diagnoses of the 831 subjects who underwent the OASIS assessment between 2001–2011. ARMS: At Risk Mental State; OCD: Obsessive Compulsive
Disorder; ADHD: Attention Deﬁcit Hyperactivity Disorder; PTSD: Post-Traumatic Stress Disorder.
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ties with interpersonal relationships as well as substantially
compromised subjective quality of life [5] are often observed
[1,80,71,49]. The diagnosis of comorbid conditions at the OASIS
team is usually performed during the baseline assessment (Fig. 7).
The SCID-1 and SCID-2 are used both to assess any co-morbid
diagnoses. Quantitative measures of psychopathology are further
obtained using the Hamilton Depression and Anxiety scale and the
PANSS. Most of the ARMS had at least one comorbid diagnosis,
mainly relating to anxiety and depressive domains, in line with
recent evidence in high risk samples [22].
3.2. Treatment
3.2.1. Logistical demands
The overall screening assessment of the OASIS team is quite
demanding. The initial screening assessment, taking place over aFig. 6. ARMS subgroups in the OASIS team 2001–2011 (n = 290). The basic
symptoms group is not represented as it was added only in the most recent years.
APS: Attenuated Psychosis Syndrome; BLIP: Brief Limited Intermittent Psychotic
Episode; GRD: Genetic and Deterioration Syndrome.session of 2 hours, involves a psychiatrist and/or a clinical
psychologist. The subsequent baseline assessment involves two
sessions of two hours each to complete all the CAARMS subscales
(2 hours), an assessment of life events and a neuropsychological
assessment (2 hours). The OASIS service currently consists of one
part-time consultant psychiatrist, two psychiatrists, three clinical
psychologists, a team-leader, and a team administrator. Thanks to
the integrated research programme, the team also beneﬁts from a
number of clinical research workers, clinical psychologist trainees
and psychatrists in training. After the OASIS assessment (i.e. pre-
screening, screening, baseline) the clients are taken on by the
OASIS team for a period of two years at a frequency determined by
their clinical needs. Assessment is repeated at one year and before
discharge.
3.2.2. Case management
During the 2-year follow-up all the OASIS patients are offered
case management. Clinicians in the OASIS service form supporting
relationships with the patients, address distress, identify treat-
ment targets such as anxiety, depression, sleep disturbance and
substance abuse, provide a perspective for patient and family, and
support the patient in social and role function [51].
3.2.3. Focused interventions
In addition to case-management, all patients are usually offered
a speciﬁc course of psychological interventions. The clinical
psychologists at the OASIS team are trained to use cognitive
behavioural therapy (CBT) and offer up to 24 sessions. Repeated
psychometric measures and discussion with the clinical team are
used to map the response to the treatment and the needs of the
patients. Most of the OASIS clients (63%) did receive some CBT: as
single ﬁrst-line therapy (33%) or in co-therapy with antidepres-
sants (11%) [25] or antipsychotics (19%) [56] (Table 2). Low-
dosages antipsychotics, more frequently Quetiapine 25-200 mg
are allowed when patients complained of persistent attenuated
psychotic symptoms impacting their overall functioning and
subjective quality of life.
Fig. 7. Co-morbid diagnoses of the 290 ARMS subjects taken over at the OASIS team between 2001–2011. OCD: Obsessive Compulsive Disorder; PD: Personality Disorder.
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In general, there is an acceptance within the ﬁeld that the deﬁnition
of ‘‘psychosis’’ is somewhat arbitrary [81]. The intensity, frequency and
duration of psychotic experiences in ARMS subjects appear to vary
along continua, and deﬁning transition involves making a quantitative
distinction between a symptom severity that corresponds to one of
two categories (psychosis and non-psychosis) [73,55]. The standard
psychotic criteria are based on the DSM-III-IV or ICD-10 criteria for
schizophrenia and other psychotic disorders. DSM deﬁnes brief
psychotic disorder as an illness lasting from 1 day to 1 month, with an
eventual return to the premorbid level of functioning. Under these
criteria psychosis can be diagnosed if one psychotic symptom occurs
for one day so this threshold is generally lower than the CAARMS,
which have longer duration criteria [19]. The OASIS criteria used are
based on the deﬁnition given by Yung et al, [75] the CAARMS criteria.
The CAARMS criteria require the occurrence of at least one fully
(positive) psychotic symptom (variably assessed on the hallucination
scale, unusual thought content/suspiciousness scale, suspiciousness,
conceptual disorganization scale) several times a week for over one
week [76]. At the time of the writing of the present manuscript, of the
290 OASIS clients, 44 subjects (15.2%) developed a psychotic episode
over the 2-year follow-up time (an ongoing research project is
monitoring the transition outcomes of ARMS up to 10 years since theirTable 2
Focused interventions in the OASIS team (n = 290, 2001–2011).
Type of interventions n %
Antipsychotics 10 3.45
Psychological support 26 8.97
Antipsychotics and CBT 55 18.97
Antidepressants 4 1.38
Antidepressants and CBT 32 11.03
CBT 98 33.79
Antipsychotics antidepressants and CBT 2 0.69
Monitoring only 16 5.52
Client declined 35 12.07
Missing data 12 4.14
Total 290 100
CBT: Cognitive Behavioural Therapy.initial assessment). The last transition to psychosis was observed after
1242 days, while the mean time to transition was of 375 days (Fig. 8).
The transition rates declined over the recent years and this
phenomenon has already been observed in other established
prodromal services [79]. Possible causes of the apparent decline in
transition rate include:
 treatment of high risk patients preventing or delaying the
psychosis onset;
 a lead time bias, that is, earlier detection resulting in transitions
seemingly occuring later;Fig. 8. Kaplan Meier survival estimate of transition to psychosis up to 10 years in
290 ARMS subjects. The last transition was observed after 1242 days (dotted line).
The mean time to transition was of 375 days (CI95% from 280 days to 470 days,
median 313 days).
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at risk being referred to high risk services, possibly as a result of
these services and their intake criteria becoming more well
known [79].
Of all the clients with an ARMS, there were only few cases of
serious self-harm but there were no completed suicides. The
longitudinal outcomes of the OASIS patients and the clinical
predictors of psychosis transition have been comprehensively
addressed in separate papers [29,11].
3.2.5. Integration with ﬁrst episode services
As mentioned above about a third (32%) of the individuals
assessed by the OASIS team were already psychotic at the time of
their initial assessment with the team. The OASIS team therefore
was not only successful in identifying people with an ARMS but
also in identifying people with a ﬁrst episode of psychosis. Thanks
to the close links with the local ﬁrst episode teams these subjects
were taken on by a few days minimizing the impact of untreated
psychosis (DUP).
3.2.6. OASIS in prison
In the last two decades the UK government has encouraged for
prisoners to receive the same range and quality of services as they
would in the community. From 2009 onwards the OASIS team has
been working in a local prison to develop a screening instrument
for ARMS in a prison setting. This study established the need for an
early intervention service in prison [45]. In 2011 we received
funding to roll-out the OASIS in Prison team which in parallel to the
community OASIS team provides an intervention package aiming
at the prevention of psychosis. Treatment starts in prison and
prisoners are seen by the standard OASIS team upon release. If this
innovative approach proves as beneﬁcial as our pilot work
suggests, it will lead to a fundamental reorganisation of mental
health services in the prison setting with a bigger emphasis on
prevention and early intervention.
3.2.7. Economic considerations
The economic impact of the OASIS team has been evaluated using a
modelling approach. Based on the OASIS data we performed one of the
ﬁrst economic studies of an early detection service [69]. A decision
model approach was applied to compare the costs associated with the
OASIS team versus the cost of treatment as usual for people presenting
with a ﬁrst episode of psychosis without having had prior contact with
specialized mental health services. The model was run for two years.
During the ﬁrst year, early detection was more expensive than care as
usual as the OASIS patients were receiving care that would not be
matched by care as usual. However, over the two years period the
OASIS team produced signiﬁcant savings mainly associated with the
prevention of transition to psychosis and the beneﬁts associated with
a short duration of untreated psychosis [69]. A recent review of the
economic impact of early detection and early intervention concluded
that the data available for early detection is preliminary and that
studies of the long term outcome of early detection and the associated
potential economic are required [70]. This type of study is currently
being carried out at the OASIS team.
3.3. Research at the OASIS team
3.3.1. Clinical Academic Groups (CAGs): advanced model for
integrated research
Recently, the mental health services in South London and
The Maudsley underwent a profound restructuring with the
advent of the new Clinical Academic Groups (CAGs) for
integrated research. Integrated research aims at coordinating
research programmes (audits, students research) between theNHS and the Institute of Psychiatry (King’s College London). In
particular, the clinical-academic partnership has been devel-
oped to improve lasting legacy of a ‘‘research culture’’ within
the clinical teams: feedback results to the teams to inform
clinical practice, to inform service development, clinical
decision making and foster innovation. Furthermore, an
innovations ‘‘component’’ is developed within services/path-
ways, where new ideas and questions are welcomed, and
turned into researchable projects. The aim of the new CAGs is
also to obtain funds within the pathway to allow growth and
implementation of innovations and ultimately to lead large-
scale translational research projects that will shape clinical
practice and health policy.
3.3.2. Neuroimaging in the ARMS
The OASIS team is closely linked to the Department of Psychosis
Studies, Institute of Psychiatry, led by professor Philip McGuire.
The OASIS-IoP team is one of the most active research groups in the
ﬁeld of neuroimaging studies of the pre-psychotic phases of
psychoses. The Department of Psychosis currently hosts a number
of national and international neuroimaging grants aimed at
clarifying the neurobiological correlates of an impending risk of
psychosis. A detailed discussion of the potentials and limits of
imaging studies in the ARMS is out of the scope of the present
paper. However, a large number of OASIS-IoP imaging studies has
uncovered signiﬁcant alterations in the structure [28,31,16],
function [26,27,32,33], connectivity [10] of the brain [52]. The
OASIS-IoP research team has also been the ﬁrst to show that the
ARMS is associated with neurochemical alterations
[34,30,35,18,20] of subcortical dopaminergic neurotransmission.
The most important imaging studies performed at the OASIS team
and published in the top impact-factor psychiatric journals are
summarized in Table 3.
3.3.3. Other research at the OASIS team
The OASIS researchers also investigated psychopathological
dimensions in subjects with an ARMS using factor analysis and
found that both the negative and the cognitive dimension scores
were signiﬁcantly associated with transition to psychosis during
subsequent follow up [11]. In close collaboration with colleagues
in Australia we have also recently submitted a paper which
examines the structure of the ARMS using latent class analysis in a
large sample (n = 315) and which found that ARMS who scored
highest on all items of the CAARMS, had the lowest GAF score and
were unemployed were also characterized by the highest
transition rate to psychosis (Valmaggia et al. submitted to
Psychological Medicine).
As the OASIS team only sees help-seeking individuals we
explored the levels of illness insight in ARMS and found that is
impaired [48]. In a further investigation we compared
individuals who were referred to OASIS but either failed to
attend for assessment (‘non-attenders’), or disengaged after
assessment (‘disengagers’), with individuals who were engaged
and managed by the service (‘help-seekers’). Over one ﬁfth of
those referred to services for people at high risk of psychosis do
not attend or engage. However, many of this subjects require
mental health care, and a substantial proportion has, or will
later develop, psychosis. A more assertive approach to assess
individuals who are at high risk of psychosis but fail to engage
may be indicated [39]. We also [29] studied the impairment in
psychosocial functioning in the pre-psychotic phases showing
that they play a signiﬁcant role in the etiopathology of the
disease onset. Compared with a demographically-matched
general population, the ARMS were more likely to live in
communal establishments or at home with their parents and
had higher rates of unemployment. Baseline unemployment
Table 3
Neuroimaging studies published by the OASIS-IoP team in the top impact-factor psychiatric journals (updated up to dec 2011).
Author Year Journal Technique Main ﬁnding
McGuire [52] 2008 Trends in Pharmacological
Sciences
Review Systematic review addressing the potentials of functional neuroimaging
in the diagnosis of schizophrenia and in the development of new drugs
for its treatment
Stone [65] 2009 Biological Psychiatry [11] MRS Glutamate function is perturbed in ARMS and associated with a reduction
in gray matter volume in brain regions thought to be critical to the
pathogenesis of the disorder
Howes [42] 2009 Archives of General
Psychiatry
[18F-DOPA] PET Dopamine overactivity in the associative striatum predates the onset of
schizophrenia and is correlated with the severity of symptoms and
neurocognitive dysfunction
Fusar-Poli [30] 2010 Archives of General
Psychiatry
fMRI and [18F-DOPA] PET Direct correlations between altered prefrontal cortical function and
subcortical dopamine synthesis capacity in the ARMS
Stone [66] 2010 Biological Psychiatry [11H] MRS and [18F-DOPA] PET The relationship between hippocampal glutamate and striatal dopamine
systems is altered in ARMS and related to the risk of transition to psychosis
Fusar-Poli [35] 2011 Archives of General
Psychiatry
fMRI and [11H] MRS Altered prefrontal, hippocampal, and temporal function in people with an
ARMS is related to a reduction in thalamic glutamate levels, and this
relationship is different from that in healthy controls
Fusar-Poli [34] 2011 Molecular Psychiatry fMRI and [18F-DOPA] PET Altered prefrontal activation in ARMS is related to elevated striatal dopamine
function. These changes reﬂect an increased vulnerability to psychosis and
predate the ﬁrst episode of frank psychosis
Howes [43] 2011 American Journal of
Psychiatry
[18F-DOPA] PET The ARMS psychotic transition group had greater striatal dopamine synthesis
capacity than did the healthy comparison subjects and was correlated with
symptom severity
Mechelli [53] 2011 Archives of General
Psychiatry
Multicenter VBM In the ARMS, reduced left parahippocampal volume was speciﬁcally associated
with the later onset of psychosis. Alterations in this region may be crucial
to the expression of illness
Allen [4] 2011 Schizophrenia Bulletin fMRI An altered relationship between middle temporal lobe function and
dopamine storage/synthesis capacity exists in the ARMS and may be related
to psychosis vulnerability
Allen [3] 2011 Schizophrenia Bulletin fMRI and [18F-DOPA] PET In ARMS people increased activation in a network of cortical and subcortical
regions may predict the subsequent onset of illness
Valli [68] 2011 Biological Psychiatry fMRI and [11H] MRS In ARMS individuals, medial temporal dysfunction seemed related to a loss
of the normal relationship with local glutamate levels
Fusar-Poli [16] 2011 Schizophrenia Bulletin Voxel-based meta-analysis Vulnerability to psychosis is associated with consistent gray matter decreases
in prefrontal and temporolimbic areas. The onset of full disease is
accompanied by temporoinsular, anterior cingulate, and cerebellar reductions
Fusar-Poli [32] 2011 Schizophrenia Bulletin fMRI The normalization of the abnormal prefrontal response during executive
functioning is associated with the longitudinal psychopathological
improvement of prodromal symptoms
ARMS: At Risk Mental State; DOPA: Dopamine; MRS: Magnetic Spectroscopy; PET: Postitron Emission Tomography; VBM: Voxel Based Morphometry; fMRI: functional
Magnetic Resonance Imaging.
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an increased risk of developing a psychotic episode within the
following two years.
4. Discussion
Despite the great burden of work undertaken over the past
decade, the OASIS team is facing some crucial challenges. For
example, there is recent concern across available literature for the
putative ‘‘high number’’ of false positives who are not actually at
risk of psychosis, with a declining transition risk observed over the
recent years [82]. We feel these concerns are overstated.
Comparatively, the predictive value of high risk diagnostic criteria
should not be considered so low: the yearly conversion risk from
mild cognitive impairment to dementia is 12% per year [24], and
conversion from prediabetes to diabetes is about 11% per year [67].
The biggest limitation is that the number of individuals in the
community meeting ARMS criteria remains unknown [59] so the
available instruments are not indicated for screening in the generalpopulation [78]. Even less is known about the outcome among the
group of ARMS subjects who do not convert to psychosis as a few
studies only provided characteristics of those subjects who did not
develop psychosis [64]. At the psychopathological level, some
discussion is emerging around the fact that the CAARMS transition
criteria are too weighted towards positive psychotic symptoms
[23]. As a result, the ARMS subjects who develop severe negative
symptoms or functional impairments (but not severe positive
symptoms) can still be categorized as not having made a transition
[81]. Furthermore it is unclear whether the OASIS participants who
will not develop any psychotic disorder will convert to another
mental disorder. For example, there is new emerging evidence
indicating that bipolar disorders are preceded by a prodromal
phase with distinct psychopathological features [6]. Another
recent study indicated that higher psychotic experiences signiﬁ-
cantly increased the risk of later hospitalization for psychiatric
disorders other than schizophrenia spectrum disorders [72].
Consequently it is becoming clear than transition to psychosis
versus clinical remission are only some of the possible outcomes,
the others being persistence of ARMS symptoms and development
Fig. 9. Vulnerability to psychosis is present as a continuum in the general population as aspeciﬁc psychotic-like experiences. The clinical high risk state for psychosis is deﬁned
when distress and disability trigger help-seeking behaviours in presence of speciﬁc signs or symptoms (attenuated psychotic symptoms). The longitudinal course of the high
risk state may include outcomes other than psychotic disorders such as the development of bipolar disorders, anxiety or depressive disorders, substance abuse or clinical
remission.
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(Fig. 9).
At the level of treatments, there are no established interven-
tions for reducing the ARMS symptoms or preventing psychosis
and urgent large-scale research is needed. The speciﬁc concern is of
unnecessary treatment [82,13], in particular with antipsychotics
(which may have signiﬁcant effects on the brain [26,41]). In the
lack of any evidence based treatment, the safest approach is
recommended (usually psychological interventions). On the other
hand, future research is urgently required to better stratify the
different levels of risks within the OASIS samples and thus tailor
speciﬁc treatments accordingly. A number of exploratory studies
are under progress to address the safety and efﬁcacy of active
interventions in this group of patients.
5. Conclusions
With more than one thousands referrals in a decade, the OASIS
service represents one of the largest and most established
prodromal psychosis services in the world. The burden of research
evidence and the translational impact on the clinical practice
support the OASIS as a leading model for the development of
similar services worldwide.
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